Related Experiment Video
Updated: Jun 28, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Drug-resistant tuberculosis in Egyptian children using Etest
Minerva Pediatrica
|October 31, 2008
Summary
The Etest is an effective method for detecting drug-resistant Mycobacterium tuberculosis (MT) in children. This study found a 24.7% drug resistance rate in Egyptian children with tuberculosis (TB).
Area of Science:
- Microbiology
- Infectious Diseases
- Pediatrics
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly in pediatric populations.
- Accurate and rapid susceptibility testing is crucial for effective TB treatment and control.
- Drug resistance in Mycobacterium tuberculosis (MT) complicates treatment regimens and impacts patient outcomes.
Purpose of the Study:
- To determine the prevalence of drug-resistant MT in newly diagnosed Egyptian children with TB.
- To evaluate the effectiveness of the Etest as a method for detecting drug-resistant MT in this population.
- To compare Etest results with the standard proportion method for antimicrobial susceptibility testing.
Main Methods:
- Prospective study involving 150 newly diagnosed pediatric TB patients.
- Isolation and identification of MT from patient samples.
- Antimicrobial susceptibility testing using both the proportion method (Lowenstein-Jensen medium) and Etest for first- and second-line drugs.
- Determination of minimal inhibitory concentration (MIC) using Etest.
Main Results:
- The overall drug resistance rate of MT in the study population was 24.7%.
- Prevalence of resistance to first-line drugs: isoniazid (5.4%), rifampicin (2.7%), streptomycin (6.8%), ethambutol (1.4%).
- Multidrug resistance (MDR) prevalence was 2.7%; resistance to second-line drugs (amikacin, ciprofloxacin) was also observed.
- Etest demonstrated high overall agreement (94.5-100%) with the reference method, with 97.89% specificity and 81.8% sensitivity.
Conclusions:
- Etest is a reliable and accurate alternative method for antimicrobial susceptibility testing of Mycobacterium tuberculosis in pediatric cases.
- The findings highlight the importance of susceptibility testing in guiding treatment for drug-resistant TB in children.
- Etest facilitates rapid detection of drug resistance, aiding in timely therapeutic interventions.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
